Super Office Director, Office of Therapeutic Products (OTP)

Food and Drug Administration • Silver Spring, MD • Posted July 13, 2026

About the Role

Summary This position is being filled under a stream-lined hiring authority, Title 21 of the United States Code (21 US Code 379d-3a) as amended by the 21st Century Cures Act of 2016, section 3072 and the Consolidated Appropriations Act of 2023, Section 3624. The candidate selected for this position will serve under a career or career-conditional appointment and be paid under the provisions of this authority. This position is being recruited based on the Title 21 Pay Table 6, Band H. . Responsibilities Oversees planning, development, and direction of patient-focused, risk-based strategies to secure safety, efficacy, and quality of cellular, tissue, gene therapy, therapeutic vaccines, plasma-derived/coagulation products, and related devices. Advises the Center Director and other officials on the Food and Drug Administration’s (FDA) regulatory and enforcement responsibilities and possible risks. Implements programs and projects to identify, assess, and prioritize the public health signifi...